Market Overview:
The global sulfadiazine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for generics drugs and growing awareness about the benefits of using sulfadiazine. Based on type, the global sulfadiazine market can be segmented into purity 98%, purity 99% and others. The purity 98% segment is expected to account for a major share of the global sulfadiazine market during the forecast period. This segment is anticipated to grow at a CAGR of XX%. Based on application, the global sulfadiazine market can be divided into hospital and clinic. The hospital segment is projected to hold a dominant position in this market during the forecast period owing to an increase in incidence rates of infectious diseases across globe.
Product Definition:
Sulfadiazine is an antibiotic used to treat a wide variety of bacterial infections. It is also used to prevent or slow the progression of rheumatoid arthritis.
Purity 98%:
Purity 98% is a crystalline form of Sulfadiazine. It is a topical antifungal drug that works by killing the fungal infection. The drug has no known side effects and hence it can be used for prolonged periods with no ill effect on the patient. Moreover, it also does not affect non-targeted organisms such as bacteria and other pathogens in the body thereby increasing its safety profile compared to other drugs of this class available in the market today.
Purity 99%:
Purity 99% is a colorless and highly viscous liquid, which contains almost no impurities. It is manufactured by the crystallization of pure benzene. Purity 99% has several industrial applications such as in the production of sulfuric acid; it acts as a source for sulfuric acid production and also provides other chemicals such as phosphoric acid, nitric acid, hydrochloric acid and urea.
Application Insights:
The global sulfur mustard market is segmented on the basis of application into hospital, clinic and others. The hospital segment dominated the overall industry in terms of revenue in 2017. Sulfadiazine is widely used for various skin conditions such as burns, eczema and psoriasis. It is also used to treat chickenpox and shingles (shingle rash). However, high cost prevents its use extensively outside hospitals.
Sulfur mustard has a broad spectrum against fungal infections including candida virus (thrush), penicillin-resistant staphylococcal infection as well as Aspergillus flavus & fumigatus species that are responsible for allergic reactions resulting in severe blistering & peeling of skin especially during winters when there are higher incidences of fungal infections due to low immunity levels caused by nutritional deficiency or vitamin D deficiency or both.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of increasing incidence rates of skin diseases and rising awareness about personal hygiene. In addition, high adoption rate for technologically advanced products is also likely to drive regional growth over the next six years.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rapid economic development coupled with improving healthcare infrastructure in emerging countries such as China and India. Furthermore, growing medical tourism industry will also boost product demand in Asia Pacific region over the coming years.
Growth Factors:
- Increasing prevalence of infectious diseases: The incidence of infectious diseases is increasing globally, which is driving the demand for sulfadiazine.
- Rising awareness about the benefits of sulfadiazine: There is a growing awareness among healthcare professionals and consumers about the benefits of sulfadiazine, which is propelling its demand.
- Growing use of sulfadiazine in combination therapies: Sulfadiazine is increasingly being used in combination therapies to achieve better results, thereby driving its market growth.
- Technological advancements in sulfadiazine manufacturing: The technological advancements in sulfadiazine manufacturing are resulting in improved quality and efficiency, thus boosting its market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sulfadiazine Market Research Report
By Type
Purity 98%, Purity 99%, Others
By Application
Hospital, Clinic
By Companies
TCI, LGM Pharma, HBCChem, Alfa Chemistry, Toronto Research Chemicals, TOKU-E, AlliChem, Waterstone Technology, City Chemical, EDQM, 3B Scientific, Wako Pure Chemical Industries, Pfaltz & Bauer, J & K SCIENTIFIC, Meryer (Shanghai) Chemical Technology, BeiJing Hwrk Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Sulfadiazine Market Report Segments:
The global Sulfadiazine market is segmented on the basis of:
Types
Purity 98%, Purity 99%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TCI
- LGM Pharma
- HBCChem
- Alfa Chemistry
- Toronto Research Chemicals
- TOKU-E
- AlliChem
- Waterstone Technology
- City Chemical
- EDQM
- 3B Scientific
- Wako Pure Chemical Industries
- Pfaltz & Bauer
- J & K SCIENTIFIC
- Meryer (Shanghai) Chemical Technology
- BeiJing Hwrk Chemicals
Highlights of The Sulfadiazine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 98%
- Purity 99%
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sulfadiazine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sulfadiazine is an antibiotic medication used to treat a variety of infections. It works by killing the bacteria that is causing the infection.
Some of the major players in the sulfadiazine market are TCI, LGM Pharma, HBCChem, Alfa Chemistry, Toronto Research Chemicals, TOKU-E, AlliChem, Waterstone Technology, City Chemical, EDQM, 3B Scientific, Wako Pure Chemical Industries, Pfaltz & Bauer, J & K SCIENTIFIC, Meryer (Shanghai) Chemical Technology, BeiJing Hwrk Chemicals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sulfadiazine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sulfadiazine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sulfadiazine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sulfadiazine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sulfadiazine Market Size & Forecast, 2018-2028
4.5.1 Sulfadiazine Market Size and Y-o-Y Growth
4.5.2 Sulfadiazine Market Absolute $ Opportunity
Chapter 5 Global Sulfadiazine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sulfadiazine Market Size Forecast by Type
5.2.1 Purity 98%
5.2.2 Purity 99%
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sulfadiazine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sulfadiazine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sulfadiazine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sulfadiazine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sulfadiazine Analysis and Forecast
9.1 Introduction
9.2 North America Sulfadiazine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sulfadiazine Market Size Forecast by Type
9.6.1 Purity 98%
9.6.2 Purity 99%
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sulfadiazine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sulfadiazine Analysis and Forecast
10.1 Introduction
10.2 Europe Sulfadiazine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sulfadiazine Market Size Forecast by Type
10.6.1 Purity 98%
10.6.2 Purity 99%
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sulfadiazine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sulfadiazine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sulfadiazine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sulfadiazine Market Size Forecast by Type
11.6.1 Purity 98%
11.6.2 Purity 99%
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sulfadiazine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sulfadiazine Analysis and Forecast
12.1 Introduction
12.2 Latin America Sulfadiazine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sulfadiazine Market Size Forecast by Type
12.6.1 Purity 98%
12.6.2 Purity 99%
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sulfadiazine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sulfadiazine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sulfadiazine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sulfadiazine Market Size Forecast by Type
13.6.1 Purity 98%
13.6.2 Purity 99%
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sulfadiazine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sulfadiazine Market: Competitive Dashboard
14.2 Global Sulfadiazine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 TCI
14.3.2 LGM Pharma
14.3.3 HBCChem
14.3.4 Alfa Chemistry
14.3.5 Toronto Research Chemicals
14.3.6 TOKU-E
14.3.7 AlliChem
14.3.8 Waterstone Technology
14.3.9 City Chemical
14.3.10 EDQM
14.3.11 3B Scientific
14.3.12 Wako Pure Chemical Industries
14.3.13 Pfaltz & Bauer
14.3.14 J & K SCIENTIFIC
14.3.15 Meryer (Shanghai) Chemical Technology
14.3.16 BeiJing Hwrk Chemicals
